Will IP hurt ventilator production amid COVID-19 pandemic?
With the UK facing a shortage of ventilators needed to treat critically-ill patients suffering from COVID-19, earlier this week Prime Minister Boris Johnson called on manufacturers to switch their production lines to address the shortage.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
26 May 2020 Attempts to reassure ventilator manufacturers that they will be protected from IP litigation revealed holes in the UK statute book, argues Debra Goldwyn of Wedlake Bell.
31 March 2020 In order to remove IP obstacles in the fight against the COVID-19 pandemic, a group of scientists, lawyers and entrepreneurs have launched an initiative urging companies to free their IP.